首页> 外文会议>European Congress of Immunology >Lack of response to classic treatment is associated with anti-cyclic citrullinated peptide antibodies but not with drb1-se status in patients with recent-onset rheumatoid arthritis
【24h】

Lack of response to classic treatment is associated with anti-cyclic citrullinated peptide antibodies but not with drb1-se status in patients with recent-onset rheumatoid arthritis

机译:缺乏对经典治疗的反应与抗循环瓜氨酸肽抗体有关,但近期发病类风湿性关节炎的患者没有使用DRB1-SE状态

获取原文

摘要

Introduction: It is known the relationship between DRB1-SE(+) alleles, antiCCP antibodies and RF and the most severe forms of RA. Therefore our objective was to evaluate these aspects in patients did not respond to treatment with DMARDS. Patients and methods: We studied 153 patients (42 non-responses to classical DMARDs). Results: In the non-responsive patients we found a higher frequency of antiCCP antibodies (p=0.03; OR=3.79) and DRB1*0405 allele (p=0.012; OR=6.31. However, the logistic regression analysis associated non-responsiveness to classical DMARDs solely with the presence of antiCCP antibodies (p=0.025; OR 3.17). Conclusions: The presence of antiCCP antibodies is associated to non-responsiveness to the initial treatment with classical DMARDs.
机译:介绍:已知DRB1-SE(+)等位基因,抗冲突抗体和RF与最严重的RA之间的关系。因此,我们的目标是评估这些方面的患者没有反应DMARD的治疗。患者和方法:我们研究了153名患者(42名对古典DMARDS的非反应)。结果:在非响应患者中,我们发现了较高频率的抗癌抗体(P = 0.03;或= 3.79)和DRB1 * 0405等位基因(P = 0.012;或= 6.31。但是,Logistic回归分析相关的非响应性仅在存在抗癌抗体的情况下古典DMARD(P = 0.025;或3.17)。结论:抗癌抗体的存在与与古典DMARD的初始治疗的非反应性有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号